Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study
Cancer Chemotherapy and Pharmacology · 2025
DOI: 10.1007/s00280-024-04734-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Ching-Yuan Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, 500209, Taiwan. Hauptthemen laut MEDLINE: Pemetrexed, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Endoglin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chung Shan Medical University Hospital, Taiwan National Science and Technology Council, Changhua Christian Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, 500209, Taiwan.
- Division of Thoracic Surgery, Department of Surgery, Yunlin Christian Hospital, Yunlin, 648106, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, 40227, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.
- Institute of Medicine, Chung-Shan Medical University, Taichung, 40201, Taiwan.
- Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan.
Förderung
- Chung Shan Medical University Hospital
- Taiwan National Science and Technology Council
- Changhua Christian Hospital
Zitieren
APA
Cheng, C. Y., Chuang, W. C., Lin, C. P., Li, C. H., Chang, H. Y., Wu, W. J., Wu, M. F., & Ko, J. L. (2025). Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04734-9
Vancouver
Cheng CY, Chuang WC, Lin CP, Li CH, Chang HY, Wu WJ, et al. Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04734-9
BibTeX
@article{Cheng2025,
author = {Cheng, Ching-Yuan and Chuang, Wen-Chen and Lin, Ching-Pin and Li, Che-Hsing and Chang, Hui-Yi and Wu, Wen-Jun and Wu, Ming-Fang and Ko, Jiunn-Liang},
title = {Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study},
journal = {Cancer Chemotherapy and Pharmacology},
year = {2025},
doi = {10.1007/s00280-024-04734-9}
}
EUVIMED